Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. The company operates through three segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment develops and commercializes seed technology, biotechnological events, germplasm, and seed treatments. The Crop Protection segment develops, produces, and markets adjuvants, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. In addition, the company offers HB4, a drought tolerant seed technology program. It operates in Argentina, Austria, Bolivia, Brazil, Lebanon, the United States, Italy, Paraguay, the United Kingdom, South Africa, France, Canada, Ukraine, Uruguay, and internationally. The company is headquartered in Rosario, Argentina. Bioceres Crop Solutions Corp. is a subsidiary of Bioceres LLC.
IPO Year:
Exchange: AMEX
Website: biocerescrops.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 7/19/2024 | $17.00 | Buy | Canaccord Genuity |
| 7/2/2024 | $15.00 | Buy | ROTH MKM |
| 4/6/2023 | $15.00 | Outperform | Oppenheimer |
| 9/30/2022 | $22.50 | Buy | Canaccord Genuity |
| 10/8/2021 | $21.00 | Buy | ROTH Capital |
6-K - Bioceres Crop Solutions Corp. (0001769484) (Filer)
20-F - Bioceres Crop Solutions Corp. (0001769484) (Filer)
6-K - Bioceres Crop Solutions Corp. (0001769484) (Filer)
6-K - Bioceres Crop Solutions Corp. (0001769484) (Filer)
6-K - Bioceres Crop Solutions Corp. (0001769484) (Filer)
6-K - Bioceres Crop Solutions Corp. (0001769484) (Filer)
6-K - Bioceres Crop Solutions Corp. (0001769484) (Filer)
6-K - Bioceres Crop Solutions Corp. (0001769484) (Filer)
6-K - Bioceres Crop Solutions Corp. (0001769484) (Filer)
6-K - Bioceres Crop Solutions Corp. (0001769484) (Filer)
Canaccord Genuity resumed coverage of Bioceres with a rating of Buy and set a new price target of $17.00
ROTH MKM resumed coverage of Bioceres with a rating of Buy and set a new price target of $15.00
Oppenheimer initiated coverage of Bioceres with a rating of Outperform and set a new price target of $15.00
Canaccord Genuity initiated coverage of Bioceres with a rating of Buy and set a new price target of $22.50
ROTH Capital initiated coverage of Bioceres with a rating of Buy and set a new price target of $21.00
Lake Street initiated coverage of Bioceres with a rating of Buy and set a new price target of $15.00
Total revenues in 1Q25 were $93.3 million 1Q25 net loss1 was $5.3 million and Adjusted EBITDA1 was $8.5 million Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ:BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal first quarter ended September 30, 2024. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons in this announcement are year-over-year (YoY), unless otherwise noted. Financial & Business Highlights Total revenues
Bioceres Crop Solutions Corp. (NASDAQ:BIOX) ("Bioceres" or the "Company"), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, will hold a conference call on Tuesday, November 12, 2024 at 8:30 a.m. Eastern Time to discuss its results for the fiscal first quarter ended September 30, 2024. A press release detailing these results will be issued prior to the call. Bioceres Chairman & Chief Executive Officer Federico Trucco, Chief Financial Officer Enrique Lopez Lecube and Head of Investor Relations Paula Savanti will host the conference call, followed by a question-and-an
Revenues up 18% in 4Q24, consolidating annual revenues of $465 million FY24 GAAP net income at $6.2 million and adjusted EBITDA1 at $81.4 million Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ:BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal fourth quarter and fiscal year ended June 30, 2024. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons in this announcement are year-over-year (YoY), unless otherwise noted. Financ
Bioceres Crop Solutions Corp. (NASDAQ:BIOX) ("Bioceres" or the "Company"), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, will hold a conference call on Tuesday, September 10, 2024 at 8:30 a.m. Eastern Time to discuss its results for the fourth quarter and fiscal year ended June 30, 2024. A press release detailing these results will be issued prior to the call. Bioceres Chairman & Chief Executive Officer Federico Trucco, Chief Financial Officer Enrique Lopez Lecube and Head of Investor Relations Paula Savanti will host the conference call, followed by a question
Total revenues in 3Q24 were $84.0 million 3Q24 GAAP net income was $9.8 million and adjusted EBITDA1 was $21.1 million Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ:BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal third quarter ended March 31, 2024. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons in this announcement are year-over-year (YoY), unless otherwise noted. FINANCIAL & BUSINESS HIGHLIGHTS Total reven
Bioceres Crop Solutions Corp. (NASDAQ:BIOX) ("Bioceres" or the "Company"), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, will hold a conference call on Tuesday, May 14, 2024 at 8:30 a.m. Eastern Time to discuss its results for the third quarter ended March 31, 2024. A press release detailing these results will be issued prior to the call. Bioceres Chairman & Chief Executive Officer Federico Trucco, Chief Financial Officer Enrique Lopez Lecube and Head of Investor Relations Paula Savanti will host the conference call, followed by a question-and-answer session. T
2Q24 revenues at $140.2 million, 49% higher YoY GAAP net income at $1.2 million, and adjusted EBITDA1 at $24.1 million Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ:BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal second quarter ended December 31, 2023. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons in this announcement are year-over-year (YoY), unless otherwise noted. FINANCIAL & BUSINESS HIGHLIGHTS Total r
Bioceres Crop Solutions Corp. (NASDAQ:BIOX) ("Bioceres" or the "Company"), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, will hold a conference call on Thursday, February 8, 2024 at 4:30 p.m. Eastern Time to discuss its results for the second quarter ended December 31, 2023. A press release detailing these results will be issued prior to the call. Bioceres Chairman & Chief Executive Officer Federico Trucco, Chief Financial Officer Enrique Lopez Lecube and Head of Investor Relations Paula Savanti will host the conference call, followed by a question-and-answer s
1Q24 revenues at $116.6 million, and adjusted EBITDA at $16.3 million Groundbreaking patent obtained in key product category Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ:BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the first quarter ended September 30, 2023. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons in this announcement are year-over-year (YoY), unless otherwise noted. FINANCIAL & BUSINESS HIGHLIGHTS Total re
Bioceres Crop Solutions Corp. (NASDAQ:BIOX) ("Bioceres" or the "Company"), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, will hold a conference call on Tuesday, November 14, 2023 at 8:30 a.m. Eastern Time to discuss its results for the first quarter ended September 30, 2023. A press release detailing these results will be issued prior to the call. Bioceres Chairman & Chief Executive Officer Federico Trucco, Chief Financial Officer Enrique Lopez Lecube and Head of Investor Relations Paula Savanti will host the conference call, followed by a question-and-answer s
Total revenues in 1Q25 were $93.3 million 1Q25 net loss1 was $5.3 million and Adjusted EBITDA1 was $8.5 million Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ:BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal first quarter ended September 30, 2024. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons in this announcement are year-over-year (YoY), unless otherwise noted. Financial & Business Highlights Total revenues
Bioceres Crop Solutions Corp. (NASDAQ:BIOX) ("Bioceres" or the "Company"), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, will hold a conference call on Tuesday, November 12, 2024 at 8:30 a.m. Eastern Time to discuss its results for the fiscal first quarter ended September 30, 2024. A press release detailing these results will be issued prior to the call. Bioceres Chairman & Chief Executive Officer Federico Trucco, Chief Financial Officer Enrique Lopez Lecube and Head of Investor Relations Paula Savanti will host the conference call, followed by a question-and-an
Revenues up 18% in 4Q24, consolidating annual revenues of $465 million FY24 GAAP net income at $6.2 million and adjusted EBITDA1 at $81.4 million Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ:BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal fourth quarter and fiscal year ended June 30, 2024. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons in this announcement are year-over-year (YoY), unless otherwise noted. Financ
Bioceres Crop Solutions Corp. (NASDAQ:BIOX) announced today that the United States Department of Agriculture (USDA) has favorably concluded its Regulatory Status Review (RSR) for HB4 wheat technology. The announcement can be found here: https://www.aphis.usda.gov/biotech-regulatory-status/regulatory-status-review-table. The USDA, through the Animal and Plant Health Inspection Service (APHIS), reviewed HB4 wheat and concluded that it does not pose an increased plant pest risk relative to comparator wheat plants. As such, it is not subject to regulations under the 7 CFR part 340 for organisms modified or produced through genetic engineering. The determination clears the U.S. market for pr
Bioceres Crop Solutions Corp. (NASDAQ:BIOX) ("Bioceres" or the "Company"), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, will hold a conference call on Tuesday, September 10, 2024 at 8:30 a.m. Eastern Time to discuss its results for the fourth quarter and fiscal year ended June 30, 2024. A press release detailing these results will be issued prior to the call. Bioceres Chairman & Chief Executive Officer Federico Trucco, Chief Financial Officer Enrique Lopez Lecube and Head of Investor Relations Paula Savanti will host the conference call, followed by a question
Total revenues in 3Q24 were $84.0 million 3Q24 GAAP net income was $9.8 million and adjusted EBITDA1 was $21.1 million Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ:BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal third quarter ended March 31, 2024. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons in this announcement are year-over-year (YoY), unless otherwise noted. FINANCIAL & BUSINESS HIGHLIGHTS Total reven
Bioceres Crop Solutions Corp. (NASDAQ:BIOX) announces that Chief Executive Officer Federico Trucco will speak at the 2024 BMO Global Farm to Market Conference at 9:30 a.m. Eastern Time on Thursday, May 16, 2024. Mr. Trucco will also participate in the "Agtech Disruption Across the Farming Value Chain" panel at 2:00 p.m. Eastern Time on Wednesday, May 15, 2024, and will conduct one-on-one meetings on both days. About Bioceres Crop Solutions Corp. Bioceres Crop Solutions Corp. (NASDAQ:BIOX) is a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change. To do this, Bioceres
Bioceres Crop Solutions Corp. (NASDAQ:BIOX), announced today the approval by Brazil's Ministry of Agriculture and Livestock (MAPA- Ministério da Agricultura e Pecuária) of three new bio-insecticidal/bio-nematicidal solutions derived from inactivated cells of the company's proprietary Burkholderia platform. The approval represents a significant regulatory milestone in the Brazilian market, marking the first endorsement of biological products formulated from fully inactivated microorganisms. Bioceres' most advanced bio-control solutions leverage the metabolites of inactivated microorganisms, resulting in products that demonstrate heightened effectiveness, precision, shelf-life, and formulat
Bioceres Crop Solutions Corp. (NASDAQ:BIOX) ("Bioceres" or the "Company"), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, will hold a conference call on Tuesday, May 14, 2024 at 8:30 a.m. Eastern Time to discuss its results for the third quarter ended March 31, 2024. A press release detailing these results will be issued prior to the call. Bioceres Chairman & Chief Executive Officer Federico Trucco, Chief Financial Officer Enrique Lopez Lecube and Head of Investor Relations Paula Savanti will host the conference call, followed by a question-and-answer session. T
Bioceres Crop Solutions Corp. (NASDAQ:BIOX) ("Bioceres" or the "Company"), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, will participate in the 36th Annual Roth Conference scheduled for March 17-19, 2024 to be held at The Ritz Carlton Laguna Niguel in Dana Point, California. Bioceres' Chief Financial Officer Enrique Lopez Lecube will attend the event in-person where he will conduct one-on-one meetings on Monday, March 18, and Tuesday, March 19. 36th Annual Roth Conference Date: March 17-19, 2024 Format: In-person one-on-one meetings Attendees: Chief Financia
SC 13G - Bioceres Crop Solutions Corp. (0001769484) (Subject)
SC 13D/A - Bioceres Crop Solutions Corp. (0001769484) (Subject)
SC 13D/A - Bioceres Crop Solutions Corp. (0001769484) (Subject)
SC 13G/A - Bioceres Crop Solutions Corp. (0001769484) (Subject)
SC 13G - Bioceres Crop Solutions Corp. (0001769484) (Subject)
SC 13G - Bioceres Crop Solutions Corp. (0001769484) (Subject)
SC 13G/A - Bioceres Crop Solutions Corp. (0001769484) (Subject)
SC 13D/A - Bioceres Crop Solutions Corp. (0001769484) (Subject)
SC 13G/A - Bioceres Crop Solutions Corp. (0001769484) (Subject)
SC 13G - Bioceres Crop Solutions Corp. (0001769484) (Subject)
Canaccord Genuity analyst Austin Moeller assumes Bioceres Crop Solutions (NASDAQ:BIOX) with a Buy rating and announces Price Target of $17.
Roth MKM analyst Scott Fortune reinstates Bioceres Crop Solutions (NASDAQ:BIOX) with a Buy and announces $15 price target.
Bioceres Crop Solutions (NASDAQ:BIOX) reported quarterly earnings of $0.15 per share which missed the analyst consensus estimate of $0.16 by 6.25 percent. This is a 65.12 percent decrease over earnings of $0.43 per share from the same period last year. The company reported quarterly sales of $84.000 million which missed the analyst consensus estimate of $98.500 million by 14.72 percent. This is a 10.26 percent decrease over sales of $93.605 million the same period last year.
Bioceres Crop Solutions Corp. (NASDAQ:BIOX), announced today the approval by Brazil's Ministry of Agriculture and Livestock (MAPA- Ministério da Agricultura e Pecuária) of three new bio-insecticidal/bio-nematicidal solutions derived from inactivated cells of the company's proprietary Burkholderia platform.The approval represents a significant regulatory milestone in the Brazilian market, marking the first endorsement of biological products formulated from fully inactivated microorganisms. Bioceres' most advanced bio-control solutions leverage the metabolites of inactivated microorganisms, resulting in products that demonstrate heightened effectiveness, precision, shelf-life, and formulation
Roth MKM analyst Brian Wright maintains Bioceres Crop Solutions (NASDAQ:BIOX) with a Buy and raises the price target from $20 to $21.
Bioceres Crop Solutions (NASDAQ:BIOX) reported quarterly earnings of $0.02 per share which missed the analyst consensus estimate of $0.09 by 77.78 percent. The company reported quarterly sales of $140.30 million which beat the analyst consensus estimate of $116.99 million by 19.92 percent. This is a 48.61 percent increase over sales of $94.41 million the same period last year.
Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million. • ArcelorMittal (NYSE:MT) is estimated to report quarterly loss at $2.16 per share on revenue of $15.42 billion. • AstraZeneca (NASDAQ:AZN) is expected to report quarterly earnings at $0.79 per share on revenue of $12.09 billion. • Lightspeed Commerce (NYSE:LSPD) is estimated to report quarterly earnings at $0.05 per share on revenue of $235.86 million. • Aurora Cannabis (NASDAQ:ACB) is likely to report quarterly loss at $0.01 per share on revenue of $63.39 million. • Brookfield (NYSE:BN) is projected to report quarterly earnings a
Bioceres Crop Solutions (NASDAQ:BIOX) is set to give its latest quarterly earnings report on Thursday, 2024-02-08. Here's what investors need to know before the announcement. Analysts estimate that Bioceres Crop Solutions will report an earnings per share (EPS) of $0.09. Bioceres Crop Solutions bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter. New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast). Past Earnings Performance Last quarter the company missed EPS by $0.10, which was follow
Bioceres Crop Solutions (NASDAQ:BIOX) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate of $0.06 by 166.67 percent. This is a 500 percent decrease over earnings of $0.01 per share from the same period last year. The company reported quarterly sales of $116.60 million which missed the analyst consensus estimate of $126.94 million by 8.15 percent. This is a 8.27 percent decrease over sales of $127.11 million the same period last year.